Jing Kong

Dr. Jing Kong


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 October 2021 in Digestive Diseases
Verified
Journal Article
Closed access
PDF file
YFYantao Fu
Yantao Fu
LPLiwei Pang
Liwei Pang
WDWanlin Dai
Wanlin Dai
SWShuodong Wu
Shuodong Wu
JKJing Kong
Jing Kong
Background: Acute acalculous cholecystitis (AAC) is characterized by acute necrotizing inflammation with no calculi and is diagnosed based on imaging, intraoperative, and pathological examinations. Key Message: Although AAC has been studied clinically for a long time, it remains difficult to diagnose and treat. The pathogenesis of AAC is still not fully understood, and it is often regarded as a relatively independent clinical disease that is different from acute calculous cholecystitis (ACC). Pathological studies suggest that AAC is the manifestation of a critical systemic disease, while ACC is a local disease of the gallbladder. Summary: Concerning the pathogenesis, diagnosis, and treatment of AAC, we reviewed the research progress of AAC, which will enhance the understanding of the early diagnosis and treatment of AAC.

1 November 2021 in Clinics and Research in Hepatology and Gastroenterology
Verified
Journal Article
Closed access
TRTengqi Ren
Tengqi Ren
LPLiwei Pang
Liwei Pang
WDWanlin Dai
Wanlin Dai
SWShuodong Wu
Shuodong Wu
JKJing Kong
Jing Kong

27 May 2021 in Frontiers in Oncology
Verified
Journal Article
Open access
SYShaojie Yang
Shaojie Yang
LPLiwei Pang
Liwei Pang
WDWanlin Dai
Wanlin Dai
SWShuodong Wu
Shuodong Wu
TRTengqi Ren
Tengqi Ren
JKJing Kong
Jing Kong
Hepatocellular carcinoma (HCC), the most common type of malignant tumor of the digestive system, is associated with high morbidity and mortality. The main treatment for HCC is surgical resection. Advanced disease, recurrence, and metastasis are the main factors affecting prognosis. Chemotherapy and radiotherapy are not sufficiently efficacious for the treatment of primary and metastatic HCC; therefore, optimizing targeted therapy is essential for improving outcomes. Forkhead box O (FOXO) proteins are widely expressed in cells and function to integrate a variety of growth factors, oxidative stress signals, and other stimulatory signals, thereby inducing the specific expression of downstream signal factors and regulation of the cell cycle, senescence, apoptosis, oxidative stress, HCC development, and chemotherapy sensitivity. Accordingly, FOXO proteins are considered multifunctional targets of cancer treatment. The current review discusses the roles of FOXO proteins, particularly FOXO1, FOXO3, FOXO4, and FOXO6, in HCC and establishes a theoretical basis for the potential targeted therapy of HCC.

1 January 2018 in Brazilian Journal of Medical and Biological Research
Verified
Journal Article
Open access
PDF file
LPLiwei Pang
Liwei Pang
YZYan Zhang
Yan Zhang
YWYuwen Wang
Yuwen Wang
JKJing Kong
Jing Kong
The exact pathogenesis of gallbladder adenomyomatosis is still lacking and some controversies over its diagnosis and treatment exist. Originally recognized as a precancerous lesion, adenomyomatosis is currently recognized by recent studies as a benign alteration of the gallbladder that is often associated with cholecystitis and cholecystolithiasis. Gallbladder carcinoma is an extremely malignant disease with a 5-year survival rate of less than 5%. Therefore, it is important to diagnose, differentiate, and confirm the relationship between adenomyomatosis and early-stage gallbladder carcinoma. However, the early clinical symptoms of adenomyomatosis are extremely similar to those of gallbladder stones and cholecystitis, increasing the difficulty to identify and treat this disease. This article summarizes the research progress on gallbladder adenomyomatosis, aiming to improve the understanding of the pathogenesis of adenomyomatosis and further provide insight for its clinical diagnosis and treatment.

1 November 2018 in Surgical Endoscopy
Verified
Journal Article
Closed access
PDF file
LPLiwei Pang
Liwei Pang
YZYan Zhang
Yan Zhang
YWYuwen Wang
Yuwen Wang
JKJing Kong
Jing Kong

7 September 2022 in Frontiers in Pharmacology
Verified
Journal Article
Open access
SYShaojie Yang
Shaojie Yang
WDWanlin Dai
Wanlin Dai
JWJingnan Wang
Jingnan Wang
XZXiaolin Zhang
Xiaolin Zhang
YZYuting Zheng
Yuting Zheng
JKJing Kong
Jing Kong
With its high incidence and mortality rates, cancer is one of the largest health problems worldwide. Investigating various cancer treatment options has been the focus of many domestic and international researchers, and significant progress has been made in the study of the anticancer effects of traditional Chinese medicines. Osthole, a coumarin compound extracted from Cnidium monnieri (L.) Cuss., has become a new research hotspot. There have been many reports on its anticancer effects, and recent studies have elucidated that its underlying mechanism of action mainly involves inhibiting cancer cell proliferation, inducing cancer cell apoptosis, inhibiting invasion and migration of cancer cells, inhibiting cancer angiogenesis, increasing sensitivity to chemotherapy drugs, and reversing multidrug resistance of cancer cells. This mini-review summarizes the research progress on the anticancer effects of osthole in recent years.